Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06855 ASCENTAGE-B
RT Nominal up45.100 +1.800 (+4.157%)
Date Shareholder name Reason of Disclosure Buy/Sell and
Involved Shares
Average Price per share Current Holdings % of Issued Shares
25/09/20241201(L)-57,000(L)HKD40.180(L)15,696,340(L)4.98
20/06/2024Takeda Pharmaceuticals Company Limited1001(L)+24,307,322(L)24,307,322(L)7.73
20/06/2024Takeda Pharmaceuticals International AG1001(L)+24,307,322(L)24,307,322(L)7.73
27/10/2023Zhai Yifan1316(L)94,894(L)64,638,531(L)22.30
05/10/2023Zhai Yifan1316(L)20,530(L)64,638,531(L)22.30
05/10/2023Yang Dajun1316(L)34,946(L)64,638,531(L)22.30
19/05/2023Yang Dajun1113(L)+126,000(L)64,638,531(L)22.46
19/05/2023Yang Dajun11031(L)+46,972(L)64,512,531(L)22.41
19/05/2023Ascentage Limited1113(L)+172,972(L)64,638,531(L)22.46
19/05/2023Zhai Yifan1113(L)+46,972(L)64,512,531(L)22.41
19/05/2023HealthQuest Pharma Limited1113(L)+172,972(L)64,638,531(L)22.46
19/05/2023Guo Edward Ming1113(L)+172,972(L)64,638,531(L)22.46
19/05/2023Wang Shaomeng1113(L)+172,972(L)64,638,531(L)22.46
19/05/2023Zhai Yifan11031(L)+126,000(L)64,638,531(L)22.46
19/05/2023Li Ju-Yun1113(L)+172,972(L)64,638,531(L)22.46
19/05/2023Gao Sharon Xia1113(L)+172,972(L)64,638,531(L)22.46
01/02/2023Wang Shaomeng1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023Yang Dajun1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023South Dakota Trust Company LLC1111(L)+22,500,000(L)54,652,465(L)20.73
01/02/2023HealthQuest Pharma Limited1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023Ascentage Limited1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023Zhai Yifan1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023Gao Sharon Xia1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023Li Ju-Yun1111(L)+22,500,000(L)64,465,559(L)22.40
01/02/2023Guo Edward Ming1111(L)+22,500,000(L)64,465,559(L)22.40
20/01/2023Zhai Yifan1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023Ascentage Limited1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023Wang Shaomeng1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023South Dakota Trust Company LLC1209(L)-22,500,000(L)36,299,215(L)13.77
20/01/2023JPMorgan Chase & Co.1704(L)-2,759,800(L)HKD24.372(L)10,865,023(L)
7,788,000(S)
86,913(P)
4.09
2.93
0.03
20/01/2023HealthQuest Pharma Limited1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023Guo Edward Ming1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023Li Ju-Yun1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023Gao Sharon Xia1209(L)-22,500,000(L)41,965,559(L)15.82
20/01/2023Yang Dajun1209(L)-22,500,000(L)41,965,559(L)15.82
19/01/2023JPMorgan Chase & Co.1001(L)
1403(S)
+857,400(L)
+271,000(S)
HKD24.726(L)13,624,823(L)
6,711,000(S)
86,913(P)
5.13
2.53
0.03
 1  
Remark: (L) - Long Position, (S) - Short Position, (P) Lending;
  Real time quote last updated: 24/12/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.